Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Results of a 28-day oral (gavage) repeated dose study, as well as, several (13 weeks and 2 years) dermal studies in mice and rats with triethanolamine and diethanolamine, did not warrant classification of triethanolamine, propoxylated for STOT-Re according to EU classification criteria.

Key value for chemical safety assessment

Additional information

The need for further testing for individual NLP polyols under the REACH Regulation can be significantly modified if arrangements for grouping into categories and ‘read across’, based on the principles in Annex XI can be used. The justifications and the proposed categories are set out in Part 1 of Barratt and Illing (2007). 'Read across' based on (a) the same bond linking the core moiety and the repeating unit moiety (b) molecular weight distributions. Experimental data on core substances, repeating units, selected polyols within the category and 'read across' based on bioavailabilities indicates that the propoxylated substances in this category are not classifiable in respect of their repeated dose toxicity. This categorisation for read across has also been used to justify read across for tests required by Annex VII and VIII. There is sufficient available information for an adequate hazard characterisation and a chemical safety assessment. In view of this ‘weight of evidence’ approach and the need to consider animal welfare, no further testing is proposed.

In a repeated dose oral toxicity study in rats (Wistar, OECD TG 407), 2,2',2" -Nitrilotriethanol, propoxylated was administered via gavage to 5 rats/sex/dose at 0, 100, 300, 1000 mg/kg bw for 4 weeks. No death was observed in either sex. No clinical effects were observed in both sex of all dose groups. There was no effect observed upon haematological, clinical biochemistry or macroscopic examination at any dose. Based on these results the NOAEL was considered to be = 1000 mg/kg bw/day. If at all the slight changes in thyroids of females at 1000 mg/kg were related to the treatment , they are regarded as an indirect and adaptive effect.

Repeated dose dermal toxcity tests were performed with triethanolamine and diethanolamine, in both mice and rats. In all studies (13 weeks and 2 year exposure for triethanolamine and 2 year exposure for diethanolamine) several effects were observed, including decrease in body weight gain, crusts at site of application, adaptive changes in liver, kidney and thyroid.

Justification for classification or non-classification

The findings in the available study do not warrant classification (GHS).